1. OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety. (15th March 2017) Authors: Orlando, A.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, A.; Carroccio, A.; Genova, S.; Calandruccio, G.; Vassallo, R.; Romano, C.; Magazzù, G.; Citrano, M.; Accomando, S. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS. (25th March 2019) Authors: Macaluso, F.S.; Cappello, M.; Giuffrida, E.; Fries, W.; Centritto, A.; Privitera, A.C.; Inserra, G.; Vassallo, R.; Magnano, A.; Vinci, E.; Garufi, S.; Ventimiglia, M.; Renna, S.; Orlando, R.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD). (25th March 2019) Authors: Porcari, S.; Fidanza, O.; Alibrandi, A.; Renna, S.; Cappello, M.; Siringo, S.; Privitera, A.C.; Inserra, G.; Mocciaro, F.; Magrì, G.; Carroccio, A.; Belluardo, N.; Bertolami, C.; Garufi, S.; Ventimiglia, M.; Macaluso, F.S.; Viola, A.; Cottone, M.; Orlando, A.; Fries, W. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗